News Focus
News Focus
icon url

Dr Bala

09/16/22 1:53 AM

#514321 RE: HyGro #514319

The helmet will be replaced by the DCVax-L therapy for the SOC.

icon url

X Master

09/16/22 7:41 AM

#514336 RE: HyGro #514319

Please show me the actual 5 year statistics for the methylated tumor patients. You will find a bunch of rhetoric and statical projections but no 5 year actual data. The device only provides hope. Let’s not even talk about the quality of life.
icon url

Nick119

09/16/22 8:20 AM

#514339 RE: HyGro #514319

Clearly keep repeating the same bs lmao. The optune trial had over 50% with IDH1 mutation whereas DCVax had only 7 of 331. Completely skewed results in the optune trial.

dcvax will be the new standard of care. Optune will be put in the garbage where it belongs.
icon url

biosectinvestor

09/16/22 9:22 AM

#514361 RE: HyGro #514319

It’s a device. Those were projected not real survivors for Optune. Devices do not have as rigorous testing requirements. It’s not a drug, it’s a electric skullcap.